Common Contracts

ACHILLES TX LIMITED AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • March 1st, 2021 • Achilles Therapeutics PLC • Biological products, (no disgnostic substances) • New York

• Contract Type
  Registration Rights Agreement
• Filed
  March 1st, 2021
• Company
  Achilles Therapeutics PLC
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered on the ___ day of February 2021, by and among ACHILLES TX LIMITED (Company no. 13027460) (the “Company”), ACHILLES THERAPEUTICS UK LIMITED (Company no. 10167668) (“ATUK”), CANCER RESEARCH TECHNOLOGY LIMITED (“CRT”) (Company no. 01626049) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor” (together, the “Parties”).

ACHILLES THERAPEUTICS LIMITED REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • January 8th, 2021 • Achilles Therapeutics LTD • Biological products, (no disgnostic substances) • New York

• Contract Type
  Registration Rights Agreement
• Filed
  January 8th, 2021
• Company
  Achilles Therapeutics LTD
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the day of November 2020, by and among ACHILLES THERAPEUTICS LIMITED (the “Company”) (Company no. 10167668), CANCER RESEARCH TECHNOLOGY LIMITED (“CRT”) (Company no. 01626049) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor”.